New Pfizer/BioNTech vaccine variant shows enhanced protection against COVID-19 hospitalization

Study demonstrates that the BNT162b2 SARS-CoV-2 XBB1.5 variant-modified vaccine significantly reduces the risk of COVID-19-related hospitalizations and ambulatory visits, outperforming previous vaccine versions in the face of evolving virus strains.

PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024 – Biotech Investments

EQS-News: PharmaSGP Holding SE / Key word(s): Preliminary Results/Forecast PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in

April 17, 2024

Cluster analysis identifies distinct subgroups of gestational diabetes patients

Patients with gestational diabetes show different disease progressions and therefore require personalized treatment measures. An international research team led by MedUni Vienna has now identified

June 19, 2024

HLTH23: 6 Digital Health Executives Share Key Takeaways

We reached out to six digital health executives for their key takeaways and reflections from attending the recent HLTH23 conference. Patches Seely MBA, BSN, RN,

October 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.